Market header image


You are here

2016-1212 – Consolidation - Vodis Pharmaceuticals Inc. (VP)

December 19, 2016

Vodis Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding share capital on the basis of one (1) post consolidation share for each four (4) pre-consolidation common shares.  No fractional shares will be issued. Any fraction of a share will be rounded down to the nearest whole number.

As a result, the outstanding shares of the company will be reduced to approximately 28,460,645.

The shares will begin trading on a consolidated basis and with a new CUSIP number on December 21, 2016.

The name and symbol will not change.

Please note that all open orders will be cancelled at the end of business on December 20, 2016. Dealers are reminded to re-enter their orders taking into account the share consolidation.

Trading on a Consolidated Basis:  December 21, 2016

Record Date:  December 23, 2016

NEW CUSIP:  92858L202

NEW ISIN:  CA 92858L2021


If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail:

CSE Listing(s):



Latest CSE News

Upcoming Events